XLJDOD compound granule not checked
Jiangsu Famous Medical Technology Co., Ltd.
FollowEvery change as it happens, and a Monday email
Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Treatment will begin within 3 months after standard adjuvant chemotherapy and compliance will be continuously monitored. XLJDOD will be taken twice a day, infused with warm water, 1 hour after lunch and dinner. One course of treatment will take 28 days in 1 month, and 2- to 3-day rest. Treatment will continue for 6 courses.”In the company’s words, NCT05709249 on ClinicalTrials.gov
- Tested for
- Colon Cancer
- Main trialPhase 3
- “This study is designed as a multi-center, randomized, double-blind, placebo-controlled trial. Subjects in the intervention group will be treated with XLJDOD compound granule. Subjects in the control group will be treated with placebo (XLJDOD mimetic agent).”In the company’s words, NCT05709249 on ClinicalTrials.gov
Other drugs for Colon Cancer
- DostarlimabGSK · Phase 3
- NuvastaticNatureceuticals Sdn Bhd · Phase 3
- RC148RemeGen · AbbVie · Phase 2/3
- INCA33890Incyte Corporation · Phase 3
- CalderasibMerck & Co. · Phase 3
- PF-08634404Pfizer · 3SBio · Phase 3
Coming up1
- 1 Apr 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 1 Apr 2027 | Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026